Changes of gene expression in T lymphocytes following Golli‑MBP gene RNA interference

Xu,Juanyong; Zhu,Dandan; Shan,Jing; Fan,Yuan

doi:10.3892/mmr.2016.5850

Changes of gene expression in T lymphocytes following Golli‑MBP gene RNA interference

Authors:
- Juanyong Xu
- Dandan Zhu
- Jing Shan
- Yuan Fan
View Affiliations

Affiliations: Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Published online on: October 13, 2016 https://doi.org/10.3892/mmr.2016.5850
Pages: 4575-4580
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The major cell types expressing Golli in the immune system are the T‑lineage cells. The aim of the current study was to investigate the changes of gene expression in T lymphocytes subsequent to downregulation of the Golli‑myelin basic protein (MBP) gene. RNA interference technology was used to suppress the expression of Golli‑MBP in Jurkat cells and DNA microarray techniques were applied to investigate the alterations of gene expression profiles. The results indicated that there were 387 differentially expressed genes. In the Golli‑MBP knockdown Jurkat cells, the expression of 108 genes was enhanced, 279 genes were suppressed. Gene ontology analysis identified differentially expressed genes involved in several biological progresses, including cell adhesion and immune responses. Pathway analysis demonstrated that the majority of the differentially expressed genes (23.3%) were involved in cytokine‑cytokine receptor interaction. Subsequent to Golli‑MBP knockdown, the mechanisms that changed the biological characteristics of Jurkat cells were complex, involving numerous types of functional proteins, and metabolic and signaling pathways. However, further experiments are required to confirm these results.

View Figures

View References

1	Feng JM: Minireview: Expression and function of golli protein in immune system. Neurochem Res. 32:273–278. 2007. View Article : Google Scholar : PubMed/NCBI
2	Campagnoni AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, Landry CF, Handley VW, Newman SL, Garbay B and Kitamura K: Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem. 268:4930–4938. 1993.PubMed/NCBI
3	Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J and Campagnoni AT: The human myelin basic protein gene is included within a 179-kilobase transcription unit: Expression in the immune and central nervous systems. Proc Natl Acad Sci USA. 90:10695–10699. 1993. View Article : Google Scholar : PubMed/NCBI
4	Feng JM, Fernandes AO, Campagnoni CW, Hu YH and Campagnoni AT: The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes. J Neuroimmunol. 152:57–66. 2004. View Article : Google Scholar : PubMed/NCBI
5	Feng JM, Hu YK, Xie LH, Colwell CS, Shao XM, Sun XP, Chen B, Tang H and Campagnoni AT: Golli protein negatively regulates store depletion-induced calcium influx in T cells. Immunity. 24:717–727. 2006. View Article : Google Scholar : PubMed/NCBI
6	Slavin AJ, Maron R and Weiner HL: Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol. 13:825–833. 2001. View Article : Google Scholar : PubMed/NCBI
7	Voskuhl RR, Pribyl TM, Kampf K, Handley V, Liu HB, Feng J, Campagnoni CW, Soldan SS, Messing A and Campagnoni AT: Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout mice. J Neuroimmunol. 139:44–50. 2003. View Article : Google Scholar : PubMed/NCBI
8	Nagasato K, Farris RW, Dubois-Dalcq M and Voskuhl RR: Exon 2 containing myelin basic protein (MBP) transcripts are expressed in lesions of experimental allergic encephalomyelitis (EAE). J Neuroimmunol. 72:21–25. 1997. View Article : Google Scholar : PubMed/NCBI
9	Shiryaev SA, Savinov AY, Cieplak P, Ratnikov BI, Motamedchaboki K, Smith JW and Strongin AY: Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis. PloS One. 4:e49522009. View Article : Google Scholar : PubMed/NCBI
10	Ding M, Zeng J, Sroussi H, Yu J, Xu J, Cheng X and Fan Y: Interactions between Golli-MBP and Th1/Th2 cytokines in patients with oral lichen planus. Oral Dis. 20:205–211. 2014. View Article : Google Scholar : PubMed/NCBI
11	Allen SJ, Crown SE and Handel TM: Chemokine: Receptor structure, interactions and antagonism. Annu Rev Immunol. 25:787–820. 2007. View Article : Google Scholar : PubMed/NCBI
12	Bennett LD, Fox JM and Signoret N: Mechanisms regulating chemokine receptor activity. Immunology. 134:246–256. 2011. View Article : Google Scholar : PubMed/NCBI
13	Cheng W and Chen G: Chemokines and chemokine receptors in multiple sclerosis. Mediators Inflamm. 2014:6592062014. View Article : Google Scholar : PubMed/NCBI
14	Yu SL, Kuan WP, Wong CK, Li EK and Tam LS: Immunopathological roles of cytokines, chemokines, signaling molecules and pattern-recognition receptors in systemic lupus erythematosus. Clin Dev Immunol. 2012:7151902012. View Article : Google Scholar : PubMed/NCBI
15	Siddiqui S, Secor ER Jr and Silbart LK: Broncho-alveolar macrophages express chemokines associated with leukocyte migration in a mouse model of asthma. Cell Immunol. 281:159–169. 2013. View Article : Google Scholar : PubMed/NCBI
16	Eisen D: The clinical features, malignant potential and systemic associations of oral lichen planus: A study of 723 patients. J Am Acad Dermatol. 46:207–214. 2002. View Article : Google Scholar : PubMed/NCBI
17	Mattila R, Ahlfors E and Syrjänen S: CD27 and CD38 lymphocytes are detected in oral lichen planus lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 111:211–217. 2011. View Article : Google Scholar : PubMed/NCBI
18	Hu JY, Zhang J, Cui JL, Liang XY, Lu R, Du GF, Xu XY and Zhou G: Increasing CCL5/CCR5 on CD4⁺ T cells in peripheral blood of oral lichen planus. Cytokine. 62:141–145. 2013. View Article : Google Scholar : PubMed/NCBI
19	Zhao ZZ, Sugerman PB, Walsh LJ and Savage NW: Expression of RANTES and CCR1 in oral lichen planus and association with mast cell migration. J Oral Pathol Med. 31:158–162. 2002. View Article : Google Scholar : PubMed/NCBI